Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: September 2011

Chapter 4 - Clinical and molecular genetics of cerebral cavernous malformations

from Section 1 - Biology

References

1. Russell, D. S. & Rubinstein, L. J.Pathology of the Tumors of the Central Nervous System, 5th edn (Baltimore: Williams and Wilkins, 1989), pp. 730–736.
2. KufsH.Uber heredofamiliare Angiomatose des Gehirns und der Retina, ihre Beziehungen zueinander und zur Angiomatose der Haut. Z Gesamte Neurol Psychiatr 1928;113:651–686.
3. Rigamonti, D., Drayer, B. P., Johnson, P. C., et al. Cerebral cavernous malformations. Incidence and familial occurence. New Engl J Med 1988;319:343–347.
4. Labauge, P., Laberge, S., Brunereau, L., Lévy, C. & Tournier-Lasserve, E.Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Lancet 1998;352:1892–1897.
5. Dubovsky, J., Zabramski, J. M., Kurth, J., et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet 1995;4:453–458.
6. Craig, H. D., Günel, M., Cepeda, O., Johnson, E. W., et al. Multilocus linkage identifies two new loci for a Mendelian form of stroke, cerebral cavernous malformation, at 7p15–13 and 3q25.2–27. Hum Mol Genet 1998;7:1851–1855.
7. Gûnel, M., Awad, I. A., Finberg, K., et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. New Engl J Med 1996;334:946–951.
8. Laberge-le Couteulx, S., Jung, H. H., Labauge, P., et al. Mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 1999;23:189–193.
9. Sahoo, T., Johnson, E. W., Thomas, J. W., et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 1999;8:2325–2333.
10. Liquori, C. L., Berg, M. J., Siegel, A. M., et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 2003;73:1459–1464.
11. Denier, C., Goutagny, S., Labauge, P., et al. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 2004;74:326–337.
12. Bergametti, F., Denier, C., Labauge, P., et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 2005;76:42–51.
13. Denier, C., Labauge, P., Brunereau, L., et al. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol 2004;55:213–220.
14. Denier, C., Labauge, P., Bergametti, F., et al. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol 2006;60:550–556.
15. Labauge, P., Denier, C., Bergametti, F. & Tournier-Lasserve, E.Genetics of cavernous angiomas. Lancet Neurol 2007;6:237–244.
16. Raychaudhuri, R., Batjer, B. A. & Awad, I.Intracranial cavernous angioma: a practical review of clinical and biological aspects. Surg Neurol 2005;63:319–328.
17. Labauge, P., Krivosic, V., Denier, C., Tournier-Lasserve, E. & Gaudric, A.Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study. Arch Ophthalmol 2006;124:885–886.
18. Sirvente, J., Enjolras, O., Wassef, M., Tournier-Lasserve, E. & Labaug, P.Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations. J Eur Acad Dermatol Venereol 2009;23:1066–1072.
19. Labauge, P., Enjolras, O., Bonerandi, J. J., et al. An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families. Ann Neurol 1999;45:250–254.
20. Eerola, I., Plate, K. H., Spiegel, R., et al. KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet 2000;9:1351–1355.
21. Stahl, S., Gaetzner, S., Voss, K., et al. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex. Hum Mutat 2008;29:709–717.
22. Liquori, C. L., Penco, S., Gault, J., et al. Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts. Neurogenetics 2008;9:25–31.
23. Verlaan, D. J., Laurent, S. B., Sure, U., et al. CCM1 mutation screen of sporadic cases with cerebral cavernous malformations. Neurology 2004;62:1213–1215.
24. Verlaan, D. J., Laurent, S. B., Rouleau, G. A. & Siegel, A. M.No CCM2 mutations in a cohort of 31 sporadic cases. Neurology 2004;63:1979.
25. Cavé-Riant, F., Denier, C., Labauge, P., et al. Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with cerebral cavernous malformations. Eur J Hum Genet 2002;10:733–740.
26. Laurans, M. S., DiLuna, M. L., Shin, D., et al. Mutational analysis of 206 families with cavernous malformations. J Neurosurg 2003;99:38–43.
27. Liquori, C. L., Berg, M. J., Squitieri, F., et al. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat 2006;27:118.
28. Verlaan, D. J., Roussel, J., Laurent, S. B., et al. CCM3 mutations are uncommon in cerebral cavernous malformations. Neurology 2005;65:1982–1983.
29. Guclu, B., Ozturk, A. K., Pricola, K. L., et al. Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3. Neurosurgery 2005;57:1008–1013.
30. Liquori, C. L., Berg, M. J., Squitieri, F., et al. Deletions in CCM2 are a common cause of cerebral cavernous malformations. Am J Hum Genet 2007;80:69–75.
31. Verlaan, D. J., Siegel, A. M., Rouleau, G. A.Krit1 missense mutations lead to splicing errors in cerebral cavernous malformations. Am J Hum Genet 2002;70:1564–1567.
32. Ortiz, L., Costa, A. F., Bellido, M. L., et al. Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp deletion in exon 5 of MGC4607 (CCM2 gene). J Neurol 2007;254:322–326.
33. Zawistowski, J. S., Stalheim, L., Uhlik, M. T., et al. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 2005;14:2521–2531.
34. Voss, K., Stahl, S., Hogan, B. M., et al. Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum Mutat 2009;30:1003–1011.
35. Cau, M., Loi, M., Melis, M., et al. C329X in KRIT1 is a founder mutation among CCM patients in Sardinia. Eur J Med Genet 2009;52:344–348.
36. Knudson, A. G.Mutation and cancer: statistical analysis of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820–823.
37. Limaye, N., Boon, L. M. & Vikkula, M.From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum Mol Genet 2009;18(R1):R65–74.
38. Limaye, N., Wouters, V., Uebelhoer, M., et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 2009;41:118–124.
39. Kehrer-Sawatzki, H., et al. Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations. Acta Neuropathol 2002;104:231–240.
40. Gault, J., Shenkar, R., Recksiek, P. & Awad, I. A.Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 2005;36:872–874.
41. Gault, J., Awad, I. A., Recksiek, P., et al. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery 2009;65:138–144; discussion 144–145.
42. Akers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M. & Marchuk, D. A.Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 2009;18:919–930.
43. Pagenstecher, A., Stahl, S., Sure, U. & Felbor, U. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 2009;18:911–918.
44. Gianfrancesco, F., Esposito, T., Penco, S., et al. ZPLD1 gene is disrupted in a patient with balanced translocation that exhibits cerebral cavernous malformations. Neuroscience 2008;155:345–349.
45. Biesecker, L. G.Exome sequencing makes medical genomics a reality. Nat Genet 2010;42:13–14.